It’s never too late - balance and endurance training improves functional performance, quality of life, and alleviates neuropathic symptoms in cancer survivors suffering from chemotherapy-induced peripheral neuropathy: results of a randomized controlled trial

Table 2 Influence of group on “STEO sway path (mm) at T1” based on the regression analysis

Model including as additional covariates	Estimated group difference for ST_EO sway path (mm) at T1	95% CI	P
Primary analysis model (ITT) including
ST_EO sway path at T0	34.5	-30.0 – 100.9	0.279
Sensitivity analysis model including additionally
Patients’ age	30.4*	-38.1 – 98.8	0.088
Therapy-free time until study inclusion	27.9*	-36.2 – 91.9	0.384
Per-protocol analysis model including
ST_EO sway path at T0	32.5*	-41.1 – 106.0	0.376

Regression analysis according to the intention-to-treat- (n = 41) and per-protocol principle (n = 37); independent variable: group; dependent variable: “STEO sway path (mm) at T1”; *adjusted for STEO sway path at T0
Abbreviations: STEO semi-tandem stance with eyes open, CI confidence interval

ISSN: 1471-2407